Cleared Traditional

K955040 - AT-III CONTROL PLASMA KIT

K955040 is an FDA 510(k) clearance for AT-III CONTROL PLASMA KIT, manufactured by American Bioproducts Co.. The device is a Class 2 Hematology device with product code GGC cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K955040 · American Bioproducts Co. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1996
Decision
89d
Days
Class 2
Risk

K955040 is an FDA 510(k) clearance for the AT-III CONTROL PLASMA KIT. Classified as Control, Plasma, Abnormal (product code GGC), Class II - Special Controls.

Submitted by American Bioproducts Co. (Parisppany, US). The FDA issued a Cleared decision on January 31, 1996 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Bioproducts Co. devices

FDA 510(k) Submission Details - K955040

510(k) Number K955040 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 03, 1995
Decision Date January 31, 1996
Days to Decision 89 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 113d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGC Device Classification - Class 2, Special Controls

Product Code GGC Control, Plasma, Abnormal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGC Control, Plasma, Abnormal

All 36
Devices cleared under the same product code (GGC) and FDA review panel - the closest regulatory comparables to K955040.
COAGULATION CONTROL LEVEL 2 (ABNORMAL)
K984130 · Pacific Hemostasis · Dec 1998
COAGULATION CONTROL LEVEL 3 (ABNORMAL)
K984131 · Pacific Hemostasis · Dec 1998
LA POSITIVE CONTROL PLASMA
K961370 · Medical Diagnostic Technologies, Inc. · May 1996
CRYO CHECK LUPUS PLASMA
K952623 · Precision Biologicals, Inc. · Nov 1995
CRYO CHECK ABNORMAL REFERENCE CHECK I & II
K952624 · Precision Biologicals, Inc. · Oct 1995
STA-COAG CONTROL [P] PLUS KIT
K952338 · American Bioproducts Co. · Sep 1995